[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"attention-deficit-disorder-with-or-without-hyperactivity-adhd\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:attention-deficit-disorder-with-or-without-hyperactivity-adhd":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,45,79],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100639736","evaluating-effects-of-group-based-cbt-for-emotion-regulation-in-adult-adhd-100639736",false,"NCT07614867","Evaluating Effects of Group-based CBT for Emotion Regulation in Adult ADHD","Group-based Emotion Regulation Skills Training for Adults With ADHD: GEARS, a Quantitative and Qualitative Investigation of Treatment Effects","GEARS","Inclusion Criteria:\n\n* being diagnosed with ADHD according to DSM criteria,\n* age 18 years or above, and\n* having identified problems with emotion regulation difficulties.\n\nExclusion Criteria:\n\n* diagnosis of intellectual disability,\n* diagnosis of autism\n* substance abuse,\n* severe mental illness (e.g., severe depression, anorexia) or comorbidity requiring clinical priority,\n* difficulties allocating time to participate due to social, academic or occupational circumstances hindering engagement in treatment,\n* other ongoing psychotherapy, and\n* difficulties accepting the group setting.","ALL","18 Years",{"count":20,"type":21},150,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study will evaluate if a specific treatment for emotion regulation in ADHD, GEARS, effectively reduces symptoms of emotional dysregulation. GEARS will be evaluated through a randomized controlled trial (RCT) and a qualitative interview study.\n\nThis project aims to investigate two main questions:\n\n1. Is GEARS an effective treatment for emotion regulation difficulties in adult ADHD patients?\n2. How do participants perceive the impact of completing the GEARS treatment? Study 1 investigates research question 1 through an RCT comparing GEARS to a passive control group. Data are collected using validated measures before and after treatment\u002Fwaiting period, as well as at six and 12 months follow ups.\n\nSample size: 150 participants, ensuring sufficient statistical power to detect significant between-group differences, even with some attrition.\n\nStudy 2 examines the patients' perspectives on the treatment by interviewing 15-20 participants about their experience with GEARS. The interviews focus on GEARS' perceived impact. Interviews will be recorded, transcribed, and analyzed using thematic analysis to identify key recurring themes.",[27],"Attention Deficit Disorder With or Without Hyperactivity (ADHD)",[29,30,31],"ADHD","Group Therapy","Cognitive Behavior Therapy","RECRUITING","2026-06-03",{"date":35,"type":36},"2026-06-04","ACTUAL",{"date":38,"type":21},"2026-05-22",{"date":40,"type":21},"2029-06",{"name":42,"class":43},"Karolinska Institutet","OTHER",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":17,"minAge":53,"maxAge":54,"enrollmentInfo":55,"targetDuration":4,"studyType":22,"phases":57,"briefSummary":58,"conditions":59,"keywords":61,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":78},"100608693","evaluation-of-the-lusha-digital-application-for-children-with-adhd---feasibility-study-100608693","NCT07204873","Evaluation of the LUSHA Digital Application for Children With ADHD - Feasibility Study","Evaluation of the LUSHA Digital Application for Children With ADHD (Attention Deficit Hyperactivity Disorder) Feasibility Study","LUSHA","Inclusion Criteria:\n\n* Children aged 7-12 years\n* Already diagnosed with ADHD\n* Consulting in a participating center\n* No indication of treatment changes (no treatment or medication stabilized for 2 months)\n* Family with a smartphone compatible with downloading the app\n* Non-opposition of both parents and the child (if possible)\n\nExclusion Criteria:\n\n* Parent under guardianship or deprived of liberty","7 Years","12 Years",{"count":56,"type":21},80,[24],"Attention Deficit Disorder with or without Hyperactivity (ADHD) is a neurodevelopmental disorder characterized by a triad of symptoms combining inattention, hyperactivity, and\u002For impulsivity. It causes developmental and functional disturbances (cognitive, behavioral, and emotional) that have a detrimental impact on the child's family, school, and\u002For social life. Treatment requires psychoeducation for the child and their parents, individual treatment for the child, and finally family treatment, particularly through specific parenting skills training programs (such as the Barkley program, 1997). It is sometimes necessary to combine this with medication (psychostimulants).\n\nThis care pathway can be complex to implement in practice, due to lack of regional actors (CMPPs, medical-psychological-educational centers) and a decrease in the number of child psychiatrists in hospital services.\n\nRecently, digital applications enabling the digitization of the psychotherapeutic approach have been developed to complement and reinforce the care provided to these children, offering an immediately available non-pharmacological alternative.\n\nLUSHA is a digital application (digital game) developed in collaboration with healthcare professionals. It aims to motivate the children to change their behavior and help parents to interact with them.\n\nThe goal of this observational study is to evaluate the adoption of LUSHA app by children with Attention deficit disorder with or without Hyperactivity (ADHD) and their parents :\n\n* The primary objective of this study is to assess adherence\u002Fuse of a digital application among children with ADHD and their parents over a period of 90 days\n* The secondary objectives are to assess the clinical impact of the LUSHA digital application using validated questionnaires (i.e quality of life, behavioural, family functioning).\n\nParticipating children and their parents will be asked to use the LUSHA digital application during 3 months and to answer online surveys.",[27,60],"Children",[62,63,64,65,66,67],"Attention Deficit Disorder with or without Hyperactivity (ADHD)","Digital application","Psychoeducation","Cognitive behavioral therapy (CBT)","Familiy quality of life","Parenting skills training (Barkley program)","NOT_YET_RECRUITING","2025-09-24",{"date":71,"type":36},"2025-10-02",{"date":73,"type":21},"2025-10",{"date":75,"type":21},"2027-07",{"name":77,"class":43},"University Hospital, Grenoble",2,{"id":80,"slug":81,"hasResults":11,"nctId":82,"briefTitle":83,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":11,"sex":17,"minAge":53,"maxAge":54,"enrollmentInfo":86,"targetDuration":4,"studyType":22,"phases":88,"briefSummary":89,"conditions":90,"keywords":4,"overallStatus":68,"whyStopped":4,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":95,"completionDateStruct":97,"leadSponsor":99,"locationsCount":4},"100552944","characterize-the-links-between-sleep-emotional-dysregulation-and-learning-in-neurodevelopmental-disorders-100552944","NCT06479668","Characterize the Links Between Sleep, Emotional Dysregulation and Learning in Neurodevelopmental Disorders.","SOM-EMO-TND","Inclusion Criteria:\n\n* Subjects aged 7 to 12\n* Able to receive clear, age-appropriate information and to participate fully in the study\n* Whose legal representative(s) are able to understand the objectives and risks of the research and to give their dated and signed informed consent.\n* Subjects benefiting from a social health insurance plan (beneficiary of the legal representative(s))\n* With a diagnosis made prior to inclusion of Autism Spectrum Disorder (ASD) or Attention Deficit Disorder with or without Hyperactivity (ADHD) as defined by Diagnostic and Statistical Manual 5 (DSM-5).\n* With abbreviated intelligence quotient \\> 80 measured by Wechsler Intelligence Scale for Children version IV (WISC-IV )no more than 6 months prior to research inclusion\n* No diagnosis of: fragile X syndrome, Rett syndrome, trisomy 21, tuberous sclerosis of Bourneville, von Recklinghausen disease, Cytomegalovirus encephalitis (CMV encephalitis), congenital rubella, phenylketonuria\n* No clinically significant abnormality which, in the investigator's opinion, could interfere with the implementation of the study.\n\nExclusion Criteria:\n\n\\- Current or past neurological problem(s) (e.g. stroke, epilepsy, meningitis, head trauma with loss of consciousness of more than 15 min, concussion, brain tumor, ...).\n\ntumor, ...)\n\n* Transmeridian travel (\\> 2 time zones) in the month prior to study inclusion\n* Presence of a mood disorder (bipolar disorder or depression) according to DSM-5 criteria\n* Social jet-lag \\> 2 hours (mid-point of sleep differential during weekends vs. weekdays)\n* Modification of psychotropic medication in the 2 months prior to inclusion\n* Use of melatonin-based dietary supplement(s)\u002Fmedication(s) in the 24 hours prior to study inclusion\n* Use of psychostimulant(s) within 48 hours of study entry\n* Extreme chronotype (Morningness\u002FEveningness questionnaire score \\\u003C 10 or \\> 42)\n* Cognitive-behavioral therapies (CBT) targeting sleep disorders\n* Participation in research involving an experimental drug which may interfere with the protocol\\*.\n* Minor under guardianship\n* Subject in a period of exclusion (determined by a previous or current study)\n* Subject in emergency situation",{"count":87,"type":21},40,[24],"The aim of this protocol is to disentangle the links between symptoms of emotion dysregulation, sleep disorders and cognitive deficits by measuring the effects of an emotional induction task on childrens' sleep with autism spectrum disorders (ASD) and attention deficit hyperactivity disorder (ADHD).",[27,91],"Autism Spectrum Disorder (ASD)","2024-08-14",{"date":94,"type":36},"2024-08-15",{"date":96,"type":21},"2024-09-01",{"date":98,"type":21},"2027-07-01",{"name":100,"class":43},"University Hospital, Strasbourg, France"]